Greenwich lifesciences llc

WebApr 19, 2024 · About Greenwich LifeSciences, Inc. Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface … WebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, April 11th.The shares were bought at an average price of $11.87 per share, for a total transaction of $11,870.00. Following the completion of the transaction, the vice president now owns …

Greenwich LifeSciences - GLSI News Today - MarketBeat

WebMar 8, 2024 · Greenwich LifeSciences is getting ready to launch Phase 3 trials for its breast cancer treatment March 8, 2024 By Sarah Smith , Editor-in-Chief, InvestorPlace.com Mar 8, 2024, 3:15 pm EST March 8 ... WebApr 14, 2024 · On Friday, March 10th, Snehal Patel bought 1,000 shares of Greenwich LifeSciences stock. The stock was bought at an average cost of $12.12 per share, with a total value of $12,120.00. crystal ball vs decision tools https://dlrice.com

Greenwich LifeSciences : Announces Presentation of 5 Year Data …

WebApr 14, 2024 · Greenwich LifeSciences, Inc. ( NASDAQ:GLSI – Get Rating) CEO Snehal Patel acquired 5,000 shares of the company’s stock in a transaction dated Tuesday, April … WebApr 11, 2024 · Greenwich LifeSciences (NASDAQ:GLSI – Get Rating) had its price objective trimmed by HC Wainwright from $78.00 to $38.00 in a research report report published on Monday morning, The Fly reports. WebApr 11, 2024 · Greenwich LifeSciences has a 1-year low of $6.82 and a 1-year high of $21.50. The business has a 50-day moving average price of $15.24 and a 200 day … crypto virtual wallet

Greenwich Lifesciences Inc (GLSI) Stock Price & News

Category:Greenwich Biosciences LinkedIn

Tags:Greenwich lifesciences llc

Greenwich lifesciences llc

Greenwich LifeSciences Presents Phase IIb Data, Published at ... - BioSpace

WebGreenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients who … WebDec 1, 2024 · Investor & Public Relations Contact for Greenwich LifeSciences Dave Gentry RedChip Companies Inc. Office: 1-800-RED CHIP (733 2447) Cell: (407) 491-4498 Email: [email protected].

Greenwich lifesciences llc

Did you know?

WebApr 6, 2024 · According to the current price, Greenwich LifeSciences is 190.84% away from the 52-week low. What was the 52-week high for Greenwich LifeSciences stock? The high in the last 52 weeks of Greenwich ... WebApr 12, 2024 · Greenwich LifeSciences ( NASDAQ:GLSI – Get Rating) had its price objective reduced by stock analysts at HC Wainwright from $78.00 to $38.00 in a …

WebDec 9, 2024 · Greenwich LifeScience stock skyrockets more than 2,000% after upbeat data on breast cancer treatment Published: Dec. 9, 2024 at 2:29 p.m. ET ... -0.03%. Shares of Greenwich LifeSciences Inc. GLSI ... WebApr 10, 2024 · Currently, the analyst consensus on Greenwich LifeSciences is a Moderate Buy with an average price target of $38.00. See Insiders’ Hot Stocks on TipRanks >> GLSI market cap is currently $168.7M ...

WebGreenwich LifeSciences Inc (GLSI) Stock Price Today, News, Quotes, FAQs and Fundamentals Advertisement 3rd Party Ad. Not an offer or recommendation by … WebGet the latest Greenwich Lifesciences Inc (GLSI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

WebApr 11, 2024 · NASDAQ:GLSI opened at $12.65 on Monday. Greenwich LifeSciences has a 52 week low of $6.82 and a 52 week high of $21.50. The stock’s fifty day moving average is $15.24 and its two-hundred day ...

WebDec 13, 2024 · STAFFORD, Texas-(Business Wire)- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced the publication of a … crystal ball video styxWebApr 11, 2024 · Headline. Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the company. finance.yahoo.com - April 6 at 1:16 PM. Greenwich Hospital raises $4 million for behavioral health expansion. greenwichtime.com - April 2 at 6:15 PM. crypto vocabulaireWebJul 12, 2024 · Greenwich Lifesciences (NASDAQ: GLSI) stock is heading higher on Tuesday after the U.S. Food and Drug Administration (FDA) lifted a hold on a Phase III clinical trial.. That hold from the FDA was ... crystal ball walking stickWebChief Medical Officer, Board Member at Greenwich LifeSciences. Location: Greater Omaha Area Add to My Lists. more ... he is Managing Partner of Phenolics, LLC and PharmaPrint, LLC, both of which are nutraceutical companies, and sits on the boards of several startup companies and a charitable foundation. Dr. Daugherty served first as … crypto vocabulary listcrystal ball walmartWebDec 9, 2024 · Well, Greenwich is a clinical-stage biopharmaceutical company that calls Texas its home. And importantly, Greenwich is behind a new treatment to prevent … crystal ball wallpaperWebSep 29, 2024 · STAFFORD, Texas-- ( BUSINESS WIRE )--Greenwich LifeSciences, Inc. (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent ... crystal ball wand